Heartland factories losing ground as Biden readies manufacturing push David J. Lynch © Catalent/Catalent Catalent in Bloomington, Ind., will soon begin producing both Moderna and Johnson & Johnson coronavirus vaccines. On a 20-acre industrial site in Bloomington, Ind., tucked between a beer distributor and the local Social Security office, drugmaker Catalent is putting the finishing touches on automated production lines that will soon begin spitting out vials of two coronavirus vaccines. The core of a $120 million overhaul, the new lines are among the fastest such systems in the world, filling hundreds of vials each minute, twice as many as current models. The high-tech marvels, which automatically inspect, label and package the tiny glass containers, help explain why both Moderna and Johnson & Johnson chose Catalent to produce their coronavirus shots.
Large Volume Parenterals (LVP) Market Business Outlook, Growth, Revenue, Trends and Forecasts 2107 – BIZNEWS
biznews.co.ke - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biznews.co.ke Daily Mail and Mail on Sunday newspapers.
Catalent (NYSE:CTLT) - KeyBanc Upgrades Catalent On Industry Transformation
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.